NVP-BGT226 has entered phase I/II clinical trials for the treatment of advanced solid tumors (including breast cancer).

June 21, 2017

prudect name : NVP-BGT226 has entered phase I/II clinical trials for the treatment of advanced solid tumors (including breast cancer).
NVP-BGT226

Synonyms: CAS NO: 1245537-68-1Molecular Formula: C₂₈H₂₅F₃N₆O₂.C₄H₄O₄Molecular Weight: 650.6Purity: 98% minSolubility: In DMSOStorage: -20°C